CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer
Authors
Keywords
-
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-04
DOI
10.1007/s00262-020-02583-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blockade of DC-SIGN+ tumor-associated macrophages reactivates anti-tumor immunity and improves immunotherapy in muscle-invasive bladder cancer
- (2020) Baoying Hu et al. CANCER RESEARCH
- Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer
- (2019) Chao Lin et al. GUT
- Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
- (2019) Yosuke Togashi et al. Nature Reviews Clinical Oncology
- c-Maf-dependent Treg cell control of intestinal TH17 cells and IgA establishes host–microbiota homeostasis
- (2019) Christian Neumann et al. NATURE IMMUNOLOGY
- Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy
- (2019) Mauro Di Pilato et al. NATURE
- Connecting blood and intratumoral Treg cell activity in predicting future relapse in breast cancer
- (2019) Lei Wang et al. NATURE IMMUNOLOGY
- The multifaceted immune regulation of bladder cancer
- (2019) Anna K. Schneider et al. Nature Reviews Urology
- Targeting CCR8 induces protective antitumor immunity and enhances vaccine-induced responses in colon cancer
- (2018) Daniel O Villarreal et al. CANCER RESEARCH
- Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer
- (2018) Hangcheng Fu et al. CLINICAL CANCER RESEARCH
- Chemokines and cancer: new immune checkpoints for cancer therapy
- (2018) Nathan Karin CURRENT OPINION IN IMMUNOLOGY
- Treg Destabilization and Reprogramming: Implications for Cancer Immunotherapy
- (2018) David H. Munn et al. CANCER RESEARCH
- c-MAF-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont
- (2018) Mo Xu et al. NATURE
- Treg Fragility: A Prerequisite for Effective Antitumor Immunity?
- (2018) Abigail E. Overacre-Delgoffe et al. Cancer Immunology Research
- Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
- (2017) J. Alfred Witjes et al. EUROPEAN UROLOGY
- Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy
- (2017) Kenneth M. Felsenstein et al. Nature Reviews Urology
- CCR8+FOXp3+Tregcells as master drivers of immune regulation
- (2017) Yiftah Barsheshet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non–Small Cell Lung Cancer
- (2017) Dennis O. Adeegbe et al. Cancer Discovery
- Regulatory T cells in cancer immunotherapy
- (2016) Atsushi Tanaka et al. CELL RESEARCH
- Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells
- (2016) Marco De Simone et al. IMMUNITY
- Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer
- (2016) George Plitas et al. IMMUNITY
- Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity
- (2016) Chong T. Luo et al. NATURE
- Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
- (2016) Vassiliki A. Boussiotis NEW ENGLAND JOURNAL OF MEDICINE
- Instability of Helios-deficient Tregs is associated with conversion to a T-effector phenotype and enhanced antitumor immunity
- (2016) Hidetoshi Nakagawa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stable inhibitory activity of regulatory T cells requires the transcription factor Helios
- (2015) H.-J. Kim et al. SCIENCE
- The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment
- (2015) M. D. Sharma et al. Science Advances
- Stability and function of regulatory T cells is maintained by a neuropilin-1–semaphorin-4a axis
- (2013) Greg M. Delgoffe et al. NATURE
- STAT3 Protein Interacts with Class O Forkhead Transcription Factors in the Cytoplasm and Regulates Nuclear/Cytoplasmic Localization of FoxO1 and FoxO3a Proteins in CD4+T Cells
- (2012) Hyun-Mee Oh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Novel Foxo1-dependent transcriptional programs control Treg cell function
- (2012) Weiming Ouyang et al. NATURE
- STAT3 Protein Promotes T-cell Survival and Inhibits Interleukin-2 Production through Up-regulation of Class O Forkhead Transcription Factors
- (2011) Hyun-Mee Oh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PI3 kinase signalling blocks Foxp3 expression by sequestering Foxo factors: Figure 1.
- (2010) Matthias Merkenschlager et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells
- (2010) Weiming Ouyang et al. NATURE IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started